What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials
- 5 March 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 176 (4) , 910-927
Abstract
Atopic eczema (AE) is a common chronic inflammatory skin condition. Whilst many AE treatment options are available, the evidence to support their efficacy varies in depth and quality. In 2000, an NIHR HTA systematic review identified and evaluated existing randomised controlled trials (RCTs) of AE treatments. To ensure continuing utility, the NIHR commissioned an update to the review. Here, we present an overview of the updated report and key findings. Systematic reviews and RCTs of AE treatments that included participants with AE (criteria based or diagnosed) were identified using: MEDLINE, EMBASE, CENTRAL, LILACS, AMED, CINAHL and Cochrane Skin Group Specialised Register (searched to August 31st 2013 (RCTs) and 31st December 2015 (systematic reviews)). Outcome measures included: symptoms, AE severity, quality-of-life, and adverse effects. Study quality was assessed using the Cochrane Collaboration risk of bias tool. Of the 287 new RCTs identified, only 22 (8%) were judged to be low risk of bias. When combined with RCTs from the previous review (n= 254), we found ‘reasonable evidence of benefit’ for corticosteroids, calcineurin inhibitors, Atopiclair™, ciclosporin, azathioprine, ultraviolet light and education programmes. Interventions with reasonable evidence of ‘no benefit’ included some dietary interventions, ion exchange water softeners, multiple daily applications of topical corticosteroids and antibiotic-containing corticosteroids for non-infected AE. Many common treatments lack evidence of efficacy and warrant further evaluation. The evidence base for AE is still hampered by poor trial design and reporting. The trials included in this review were used to establish the Global Resource of Eczema Trials (GREAT) Database.Keywords
Funding Information
- National Institute for Health Research
- Applied Research Programme (RP-PG-0407-10177)
- Le Collège des Enseignants en Dermatologie de France
This publication has 266 references indexed in Scilit:
- The Effect of TJ-15 Plus TJ-17 on Atopic Dermatitis: A Pilot Study Based on the Principle of Pattern IdentificationThe Journal of Alternative and Complementary Medicine, 2012
- E‐health in caring for patients with atopic dermatitis: a randomized controlled cost‐effectiveness study of internet‐guided monitoring and online self‐management trainingBritish Journal of Dermatology, 2012
- Chinese herbal medicine research in eczema treatmentChinese Medicine, 2011
- Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trialsBritish Journal of Dermatology, 2010
- A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologistBritish Journal of Dermatology, 2009
- Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild‐to‐moderate atopic dermatitisExperimental Dermatology, 2008
- Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled studyBritish Journal of Dermatology, 2008
- What are the best outcome measurements for atopic eczema? A systematic reviewJournal of Allergy and Clinical Immunology, 2007
- Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta‐analysisJournal of the European Academy of Dermatology and Venereology, 2007
- Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trialBMJ, 2006